Research Article

The Long-Term Outcome Comparison of Different Time-Delayed Kallikrein Treatments in a Mouse Cerebral Ischemic Model

Figure 4

Administration of exogenous tissue kallikrein starting at 8 h, 24 h, and 36 h after ischemic stroke can increase BrdU+ cells (a, C–E) and BrdU+/Tuj-1+ cells (a, H–J) in the peri-infarction region. Quantitative data of BrdU+/Tuj-1+cells (b) in the peri-infarction region. compared with MCAO group. compared with the sham group. compared with the KLK 8 h group. The scale bar represents 40 μm.